The winter vomiting bug affects millions of Britons every year, but a new vaccine could help reduce the massive impact of norovirus.

A new vaccine against the winter vomiting bug, norovirus, is being tested on volunteers after preliminary findings indicated the injection elicited a “strong immune response”.

A vaccine is to be trialled on thousands of people to find out if it could protect against norovirus - a stomach bug that causes vomiting and diarrhoea. The easily spreadable winter virus can affect people of all ages and have huge consequences - often closing hospital wards, taking children out of school and keeping parents off work.

A randomised clinical trial of an mRNA vaccine against norovirus will be launched in the UK within the next two weeks, it has been announced.

A vaccine for the vomiting bug norovirus is being trialled in the UK for the first time, with the hope it could cut the “burden on the NHS”, the Health Secretary has said. The new mRNA vaccine from Moderna will enter final stages of testing within the next two weeks,

World-first vaccine for vomiting bug norovirus trialled in the UK - The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack.

A first-of-its-kind vaccine against the vomit bug norovirus is being trialled in the UK, using the same tech employed in the Covid jab. Thousands of Brits end up in hospital every year due to the highly contagious virus,